Trials / Completed
CompletedNCT04504201
Patient-centered Communication About Healthy Weight in Early Breast Cancer
Clinic-based "Patient-Centered Communication About Healthy Weight" (PCC-HW) in a Diverse Sample of Women With Early Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breast cancer patients. This study tinvestigates how messages and messaging about healthy weight can be tailored for racially diverse breast cancer survivors with obesity in order to ensure that clinic-based communications between patients and their oncology provider are patient-centered and culturally sensitive.
Detailed description
The overall goal of this research is to collect essential input for the future development of a quality improvement intervention to foster "Patient-Center Communication about Healthy Weigh in clinical practice Primary Objective: 1. Understand patient-centered perspectives on health weight communication with oncology clinicians by conducting focus groups Secondary Objective 2. Understand oncology clinician perspectives on patient center communications for healthy weight interactions through semi-structured interviews.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Focus Group | Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight. |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2020-09-29
- Completion
- 2020-09-29
- First posted
- 2020-08-07
- Last updated
- 2022-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04504201. Inclusion in this directory is not an endorsement.